CompletedNCT01770704
Clinical Care and Outcomes in Bipolarity in China
About this title
Observation Study of the Clinical Management of Bipolar Disorder
Read the official source — NCT01770704Observational studyAges 18+China
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- Beijing and 5 more locationsSee all locations and recruitment
Study information
Study start dateFebruary 2013
- Recruitment status
- Completed
- Enrollment listed in the registry
- 520
- Sponsor
- AstraZeneca
- Sponsor type
- Unknown or unclear
- Study type
- Observational
- Intervention type
- Interview / survey / observational
- Study phase
- Not clearly listed
- Locations
- China
- Age range
- Over 18 Years
- Official registry ID
- NCT01770704
- Official title
Show the full official title
Chinese Observation Study of the Clinical Management of Bipolar Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Beijing · Shenzhen · Shanghai
3 more locations
- Xi’an
- Kunming
- Hangzhou
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is AstraZeneca.
Who was this study for?
Listed age limits: from 18 years.
